Neurostimulation technology is migrating into the ophthalmology field, and the implications could be significant for the millions of patients worldwide with degenerative eye diseases, including retinitis pigmentosa and age-related macular degeneration, as well as those with moderate-to-severe dry eye disease. Companies active in this space include Second Sight Medical Products, Retina Implant AG, Pixium Vision, Nano Retina, and many others.

Cook Medical has stopped shipments and initiated a global recall of its Zilver PTX drug-eluting stent due to reports of the device’s delivery system separating at the tip of the inner catheter.